KRMD

KORU Medical Systems, Inc.

$3.16

-2.17%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Source: Yahoo Finance
AI summary

Price & performance

1M+7.5%
3M-20.6%
YTD-42.4%
1Y-18.2%
52-week range—
Beta1.12
Full chart and returns against a benchmark

Q-Score

60/ 100

Quality against peers; 50 is the peer median.

Growth67
Risk58
Performance52
Valuation51
Profitability59
Leverage70
Sentiment37
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$41.1M+22.2%
Net income-$2.6M
Net margin-6.4%+11.6 pts
Historical fundamentals

Revenue exposure

26%of revenue from outside the US
United States74%
Non Us26%
Largest customer56%
Regions, segments, customers and suppliers

Valuation

KRMDIndustryP/E—49.36P/S3.223.73EV/EBITDA—23.12P/B8.043.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate$-0.02
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate